Pregabalin Capsule
Product Images NDC 71610-930

Product Visual Gallery

This gallery contains 15 technical images submitted to the FDA as part of the official labeling for Pregabalin (NDC 71610-930). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aphena Pharma Solutions - Tennessee, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (71610 0930 30)

This is a list of pharmaceutical items, including "Casmins" and "Pregabalin". The text also contains a reference number (71610-630-30) and pricing information (£1). Additionally, there are mentions of "Capaues" and a code possibly related to the product.*

FDA Label Image

Aphena (Aphena)

FDA Label Image

Chemical Structure (Pregabalin 01)

FDA Label Image

Figure 1 (Pregabalin 02)

FDA Label Image

Figure 2 (Pregabalin 03)

FDA Label Image

Figure 3 (Pregabalin 04)

FDA Label Image

Figure 4 (Pregabalin 05)

Percent of Patients Improved This text appears to be showing the percentage of patients improved after taking different doses of Pregabalin and a placebo for pain relief. The patients were given Pregabalin 200 mg three times a day, Pregabalin 100 mg three times 2 a day, and a placebo. The chart may indicate the improvement in pain from baseline for each group of patients.*

FDA Label Image

Figure 5 (Pregabalin 06)

FDA Label Image

Figure 6 (Pregabalin 07)

FDA Label Image

Figure 7 (Pregabalin 08)

FDA Label Image

Figure 8 (Pregabalin 09)

This text provides information on responder rates at different dosages in a study. The responder rates are shown in percentages for different groups receiving a placebo and varying doses of a medication. The rates range from 22.6% to 60% for different dosages.*

FDA Label Image

Figure 9 (Pregabalin 10)

FDA Label Image

Figure 10 (Pregabalin 11)

FDA Label Image

Figure 11 (Pregabalin 12)

This is a report showing the percentage of subjects who have improved over time, specifically from baseline to week 12 in a study involving the drug Pregabalin. The list includes various percentages such as 20, 22, 40, 90, and 100.*

FDA Label Image

Figure 12 (Pregabalin 13)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.